Table 3 CML patients’ demographic features and imatinib dose
Age/Sex of CML patients | CML Patients (n = 150) | Imatinib 200 mg to 600 mg OD dose group (n = 59) | Imatinib 600 mg to 800 mg OD dose group (n = 91) |
|---|---|---|---|
Age (year) median (range) | |||
 All CML patients | 38 (15–80) | 38 (15–80) | 40 (16–66) |
 Age ≤ 38 years | 30 (15–38) | 30 (15–38) | 30 (16–38) |
 Age > 38 years | 47 (40–80) | 48 (40–80) | 47 (40–66) |
Sex, n (%) | |||
 Male | 89(59) | 37 (41.5) | 52 (58.5) |
 Female | 61(41) | 22 (36) | 39 (64) |